Live Breaking News & Updates on Hedge Funds Weigh In On Marinus Pharmaceuticals

Stay updated with breaking news from Hedge funds weigh in on marinus pharmaceuticals. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) Given Average Recommendation of "Moderate Buy" by Brokerages

Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) Given Average Recommendation of "Moderate Buy" by Brokerages
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Robertw Baird , Marinus Pharmaceuticals , Vanguard Group Inc , Sg Americas Securities , News Ratings For Marinus Pharmaceuticals Daily , Jennison Associates , Royal Bank , Schonfeld Strategic Advisors , Marinus Pharmaceuticals Inc , Cantor Fitzgerald , Analyst Recommendations For Marinus Pharmaceuticals , Hedge Funds Weigh In On Marinus Pharmaceuticals , Marinus Pharmaceuticals Company Profile , Marinus Pharmaceuticals Stock Performance , Get Free Report , Marketbeat Ratings , Strategic Advisors , Capital Partners , Get Free , Marinus Pharmaceuticals Daily ,

Robert W. Baird Reaffirms "Neutral" Rating for Marinus Pharmaceuticals (NASDAQ:MRNS)

Robert W. Baird Reaffirms "Neutral" Rating for Marinus Pharmaceuticals (NASDAQ:MRNS)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Robertw Baird , Marinus Pharmaceuticals Trading Down , Analyst Recommendations For Marinus Pharmaceuticals , Sg Americas Securities , Marinus Pharmaceuticals Company Profile , Hedge Funds Weigh In On Marinus Pharmaceuticals , Schonfeld Strategic Advisors , News Ratings For Marinus Pharmaceuticals Daily , Marinus Pharmaceuticals , Cantor Fitzgerald , Jennison Associates , Vanguard Group Inc , Marinus Pharmaceuticals Inc , Royal Bank , Free Report , Pharmaceuticals Trading Down , Get Free Report , Strategic Advisors , Capital Partners , Marinus Pharmaceuticals Daily ,

HC Wainwright Reiterates "Buy" Rating for Marinus Pharmaceuticals (NASDAQ:MRNS)

HC Wainwright Reiterates "Buy" Rating for Marinus Pharmaceuticals (NASDAQ:MRNS)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Hedge Funds Weigh In On Marinus Pharmaceuticals , Charles Schwab Investment Management Inc , Goldman Sachs Group Inc , Marinus Pharmaceuticals Trading , Analyst Recommendations For Marinus Pharmaceuticals , Royal Bank , Renaissance Technologies , Marinus Pharmaceuticals Inc , News Ratings For Marinus Pharmaceuticals Daily , Metlife Investment Management , Marinus Pharmaceuticals , Get Free Report , Life Investment Management , Schwab Investment Management , Sachs Group , Quantbot Technologies , Marinus Pharmaceuticals Daily ,

Analysts Set Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) Target Price at $20.44

Shares of Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS – Get Free Report) have earned an average rating of “Moderate Buy” from the eight brokerages that are covering the company, MarketBeat reports. One research analyst has rated the stock with a hold recommendation and seven have issued a buy recommendation on the company. The average 12-month target price […] ....

Marinus Pharmaceuticals Inc , Charles Schwab Investment Management Inc , Goldman Sachs Group Inc , Hedge Funds Weigh In On Marinus Pharmaceuticals , Marinus Pharmaceuticals , Analyst Recommendations For Marinus Pharmaceuticals , Marinus Pharmaceuticals Stock Down , Marinus Pharmaceuticals Company Profile , News Ratings For Marinus Pharmaceuticals Daily , Metlife Investment Management , Renaissance Technologies , Get Free Report , Life Investment Management , Schwab Investment Management , Sachs Group , Quantbot Technologies , Pharmaceuticals Stock Down , Get Free , Marinus Pharmaceuticals Daily , Nasdaq Mrns ,

Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) Receives Consensus Rating of "Moderate Buy" from Analysts

Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) Receives Consensus Rating of "Moderate Buy" from Analysts
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Eventide Asset Management , Marinus Pharmaceuticals , Marinus Pharmaceuticals Inc , Blackrock Inc , Analyst Recommendations For Marinus Pharmaceuticals , Jennison Associates , Marinus Pharmaceuticals Stock Performance , Hedge Funds Weigh In On Marinus Pharmaceuticals , News Ratings For Marinus Pharmaceuticals Daily , Get Free Report , Truist Financial , Asset Management , Point Capital , Get Free , Marinus Pharmaceuticals Daily ,